A collection of COVID-19 samples is being created at iMM Biobank. These biological samples will be collected from patients infected with COVID-19, and aims to increase knowledge about the virus in order to develop therapeutic responses and learn more why the virus behaves differently in different population groups.

The samples will be available to the scientific community, through the submission of projects that will be evaluated by a scientific committee that will determine the relevance and pertinence of the scientific and clinical questions raised.